Full Text
The Full Text of this article is available as a PDF (42.7 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baecklund E., Ekbom A., Sparén P., Feltelius N., Klareskog L. Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study. BMJ. 1998 Jul 18;317(7152):180–181. doi: 10.1136/bmj.317.7152.180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baecklund Eva, Askling Johan, Rosenquist Richard, Ekbom Anders, Klareskog Lars. Rheumatoid arthritis and malignant lymphomas. Curr Opin Rheumatol. 2004 May;16(3):254–261. doi: 10.1097/00002281-200405000-00014. [DOI] [PubMed] [Google Scholar]
- Brown S. Lori, Greene Mark H., Gershon Sharon K., Edwards Evelyne T., Braun M. Miles. Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum. 2002 Dec;46(12):3151–3158. doi: 10.1002/art.10679. [DOI] [PubMed] [Google Scholar]
- Ekström Karin, Hjalgrim Henrik, Brandt Lena, Baecklund Eva, Klareskog Lars, Ekbom Anders, Askling Johan. Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives. Arthritis Rheum. 2003 Apr;48(4):963–970. doi: 10.1002/art.10939. [DOI] [PubMed] [Google Scholar]
- Wolfe Frederick, Michaud Kaleb. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum. 2004 Jun;50(6):1740–1751. doi: 10.1002/art.20311. [DOI] [PubMed] [Google Scholar]